Blue Horseshoe Stocks: Huge Options Wins

Cronos Group, Inc. CRON – Recap

We’ve been tracking CRON heavily this week, after having observed its swing low of 6.50 last week, the stock has now strung together seven consecutive bullish sessions, and yesterday attained a new high of 9.95, marking a 53% increase in roughly a week.

CRON Weekly $8 & $8.50 Calls were initially targeted in our report from Tuesday morning, and those attained new highs. We’ve now seen a move from the $8 Calls from .50-1.85 for a gain of 270%, and the $8.50′s updated range runs from .30 to 1.40, a gain of 367% in just two sessions’ time.

Yesterday we mentioned that we’d also look to roll up to higher strike points with the $9 & $9.50 Calls and those produced huge gain opportunities on the day. The $9′s moved up from a low of .20 and went on to hit a dollar, for a 400% rip, while the $9.50′s took the cake with a mega run from .10 to 70, a 600% gain.

CRON looks to be gearing down a bit this morning, but at this point it owes us nothing, and was a really great midweek play for us on the options front.


CVS Health Corp. CVS – Update

We also targeted some CVS calls on Tuesday- the CVS Weekly $75 & $75.50 Calls and did very well with those right out of the gate. We have some new highs there as well thanks to a solid session yesterday.

So far we’ve seen the $75 Calls trade from 1.05 to their new high at 6.00 (+471%), while the $75.50′s have run from .84-5.00 for gains of up to 495%, continuing our stellar week of fantastic options calls.



We also provided a pair of fresh options ideas in yesterday’s report, and kept the multi-bag profit train rolling with both targets:

ETSY Weekly $45 Calls
Range:
2.40-6.70 – Max Gain: 179%

TWLO Weekly $80-82 Calls
$80 – 3.15-16.37 (+420%)
$80.50 - 2.70-7.02 (+160%)
$81 – 2.33-14.80 (+535%)
$81.50 – 2.70-10.89 (+303%)
$82 – 2.25-13.80 (+513%)



Extended Watchlist:
ANGI, ARRS, AVLR, CVNA, CYBR, SESN, SND,

Blue Horseshoe Stocks: CVS, CRON Updates

Cronos Group, Inc. CRON – Update

It was just yesterday morning that we highlighted CRON, and the solid moves the stock has been making off of its swing low of 6.50 from last week. The impressive rebound continued for another day, with yesterday’s sesison bringing a respectable intraday move and a significant increase in our observed range on the stock over the past week.

From its daily low of 8.15 the stock reached a new high of 9.58, which works out to an 18% intraday hike. From our observed low from last week, we’ve now witnessed a move up of 47% It marked the sixth consecutive bullish session for CRON, which fell just shy of testing its current 50DMA, now standing at 10.25.

We had also signaled our interest in tracking the CRON Weekly $8 & $8.50 Calls in yesterday’s premarket report, and that idea provided opportunities as well. The $8 Calls went on an impressive intraday run from .50-1.55 for a gain of 210%, while the $8.50′s pushed their way up from a low of .30 and reached 1.15, a 283% rip!

Today’ we’ll look to possibly roll up to the $9 & $9.50 Calls on CRON if it appears its run will continue.


CVS Health Corp. CVS

We also targeted some CVS calls yesterday following the company’s earnings release, highlighting the CVS Weekly $75 & $75.50 Calls and we were met with some great chances for single-session profits there as well.

The $75 Calls traded up from 1.05 and as high as 3.25 (+210%), and the $75.50′s went from .84-2.79 for gains of up to 232%
_____

Fresh Ideas:
ETSY Weekly $45 Calls
TWLO Weekly $80-82 Calls

Blue Horseshoe Stocks: TSN Recap & More

Tyson Foods Inc. TSN – Update

We started the week off yesterday by formulating some options ideas for TSN. The company had a mixed earnings call, with a beat on Q3 profits, and a miss on sales. We pointed to the technical setup of the chart as our primary reason for being interested, and as it turns out we called the bottom perfectly.

We came up with a short and longer term set of ideas, and while we may yet come back to the long terms, we are looking at the weekly calls we designated today after some solid performances. Those were the TSN Weekly $58-59.50 Calls, and all but the $58′s produced double-bag gains on the session.

$58.50 Calls – Range: .90-2.25 – Max Gain: 150%
$59 Calls – Range: .80-1.68 – Max Gain: 110%
$59.50 Calls – Range: .75-1.50 – Max Gain: 100%



Fresh Options Ideas

Our success with options over the past several weeks has been so pronounced, we see absolutely no reason to stop now, especially being in the thick of another earnings season. We’ve got another pair of earning related options ideas to bring to the table today.

Etsy, Inc. ETSY Weekly $40-50 Calls
Zillow Group, Inc. Z Weekly $48-49 Calls


Extended Watchlist:
TIS, NPTN, RNG, ACRX, MNK, EKSO, VCEL, TWLO

Blue Horseshoe Stocks: HEAR Review & More

Turtle Beach Corp. HEAR – Review

Our primary focus has always been to find near-term trading opportunities first, assigning longer-term calls a secondary priority. However, we’ve had quite a bit of good fortune this year in identifying stocks that have gone on to have considerable extended runs.

HEAR is one such stock, that we first signaled for observation on April 9th, at which time the stock was trading for as little as 2.76. Over the ensuing nine weeks, we have seen an incredible, near-continuous bull run that has resulted in new highs of 23.20 yesterday. That works out to an increase of 740% over a span of a little over two months!

Being in blue skies, there’s no telling what new highs we might see in HEAR; it’s certainly plausible to believe we may see our total observed gain reach a thousand percent at some point in the near future. At the rate things have been going, it’s certainly not an unreasonable thought.


H&R Block, Inc. HRB – Fresh Idea

We also want to provide a quick update on our bearish options idea from yesterday’s premarket report, the HRB Weekly $26-24 Puts. We formulated this range after noticing the stock getting kicked hard despite posting an earnings beat in the post-market on Tuesday.

HRB did gap down a little too far for the $26′s to see much action, but we had respectable chances to profit off of the other two contracts in the range. The $25 Puts ran from .65-1.05 for a gain of 62%, while the $24′s put up a double-bag performance with a 133% rip from .15-.35.


Galectin Therapeutics, Inc. GALT

We tagged GALT on Tuesday morning after noticing a big surge in activity, and its run has continued nicely over the course of the week.

We’ve now observed a solid 37% bullish move from 5.83-8.00, and will be on the lookout for the possibility of more new highs.


Extended Watchlist:
ENPH, CTRV, CODX, FCEL, ETSY, ONTX, MYSZ

Blue Horseshoe Stocks: XGTI Review & More

xG Technology, Inc. XGTI

We’ve seen XGTI make its way up nicely from a low of .08 subsequent to our tag of the stock late last month, but despite it already being up considerably, we reinforced our bullish opinion of it in yesterday morning’s premarket report.

The momentum we’d observed was sufficient to surmise that further opportunities could be in the cards, and our assumption was accurate indeed. We saw a strong move out of XGTI to begin the session as it traded in its full daily range from an early low of .1021 on up to a new high of .165 for an initial rip of 62%

Midday saw a pullback in the stock, which ultimately found support at .1217 before returning to .155, an added 27% swing, so there was a good chance for late-comers as well. It brought the cumulative total on northward movement for the day to a respectable 89%


Pernix Therapeutics Holdings, Inc. PTX

PTX is another one we’ve tracked in the past which we re-alerted this week on the heels of a newly-registered 52-week low on Friday. The stock made a nice move on Monday, and continued its ascent yesterday.

We witnessed a trading range from .98-1.25 which works out to a solid 28% upswing on the day, and it came on more than eight times the 3-month average volume.


Cerebain Biotech, Inc. CBBT

We tagged CBBT based on observing some abnormal volume on Monday, and despite sliding for the first half of the day, the stock did register a higher low and higher high from the session prior en route to a nice intraday swing. It traded from .53-.86, making a 62% pop and closing with strength at .85.

The company also announced yesterday that it would apply for FDA approval on its medical device which is meant to treat alzheimer’s and dementia sufferers, so that will be one storyline to continue following. (>>Read PR)


Extended Watchlist:
TTCM, HEMP, NTRI, ETSY, Z, EBIO(>>News)